Caltrate Plus
Caltrate Plus, licence 80033740: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Pfizer Consumer Healthcare, a division of Pfizer Canada ULC
- NPN or DIN-HM
- 80033740
- Status
- Inactive licence
- Licence date
- 18 July 2012
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Tocophérols, Triglycérides à chaîne moyenne, Cellulose microcristalline, Amidon prégélatinisé, Phosphate de calcium, tribasique, Poly(alcool vinylique), Croscarmellose de sodium, Amidon de maïs modifié, Ascorbate de sodium, Stéarate de magnésium, Dioxyde de titane, Rouge allura AC, Dioxyde de silicium, Bleu FD&C n° 2, Talc, Jaune FD&C n° 6, Sucrose, Poly(éthylène glycol), Sirop de maïs solide, Acacia
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1.0 Comprimé ; maximum: 2.0 Comprimé | 1.0 Jour(s) |
Uses authorised in Canada
Text supplied in English because no French text is available.
Calcium supplement with vitamins and minerals. Calcium intake, when combined with sufficient vitamin D, a healthy diet, and regular excercise, may reduce the risk of developing osteoporosis. Vitamin D to help calcium absorption. Vitamin K for the maintenance of bones. Calcium to help in the development and maintenance of bones and teeth. Helps the body metabolize carbohydrates, fats and proteins. Helps in tissue formation. Helps to maintain proper muscle function. Helps in connective tissue formation. Helps to maintain healthy skin. Helps to maintain immune function. Helps to produce and repair connective tissues. Helps to form red blood cells. Helps develop and maintain bones. Magnesium to help in the development and maintenance of bones and teeth. Manganese to help in the development and maintenance of bones. Helps maintain good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80033740
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.